Cancer antigen 125 is associated with disease status in uterine carcinosarcoma

Uterine carcinosarcoma is a rare and aggressive tumor with poor outcomes. Cancer antigen 125 is routinely used to track the disease course of ovarian cancer and has been suggested as a biomarker in other aggressive forms of uterine cancer. We sought to characterize cancer antigen 125 as a potential...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Rare Tumors
Main Authors: Ross, Malcolm Strachan, Chandler, Chelsea Kilpatrick, Matsuo, Koji, Vargo, John Austin, Elishaev, Esther, Siripong, Nalyn, Berger, Jessica Layne, Kelley, Joseph Leo, Taylor, Sarah Elizabeth
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6843728/
https://ncbi.nlm.nih.gov/pubmed/31741727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2036361319884159
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados